| Identification | Back Directory | [Name]
17-PHENYL TRINOR-13,14-DIHYDRO PROSTAGLANDIN A2 | [CAS]
130209-80-2 | [Synonyms]
ZHCXQFHXZFWVRT-BRQXMNQMSA-N
13,14-dihydro-17-phenyl-18,19,20-trinor-PGA2
17-PHENYL TRINOR-13,14-DIHYDRO PROSTAGLANDIN A2
9-OXO-15R-HYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z,10-DIEN-1-OIC ACID
5-Heptenoic acid, 7-[2-(3-hydroxy-5-phenylpentyl)-5-oxo-3-cyclopenten-1-yl]-, [1R-[1α(Z),2β(R*)]]- (9CI) | [Molecular Formula]
C23H30O4 | [MDL Number]
MFCD00135205 | [MOL File]
130209-80-2.mol | [Molecular Weight]
370.48 |
| Chemical Properties | Back Directory | [solubility ]
DMF: >100 mg/ml (from Fluprostenol); DMSO: >100 mg/ml (from Fluprostenol); Ethanol: >100 mg/ml (from Fluprostenol); PBS pH 7.2: >0.8 mg/ml (from 17-phenyl tri |
| Hazard Information | Back Directory | [Description]
17-phenyl trinor-13,14-dihydro Prostaglandin A2 is a synthetic PG analog whose biological activity has not been widely reported. The PGF2α analog latanoprost, which bears the same lower side chain features, has been approved as a pharmaceutical for the treatment of glaucoma.1 | [Uses]
17-Phenyl trinor-13,14-dihydro prostaglandin A2 is a biochemical reagent. | [Definition]
ChEBI: 17-phenyl trinor-13,14-dihydro Prostaglandin A2 is a prostanoid. | [References]
1. Alm, A., Villumsen, J., T?rnquist, P., et al. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study Ophthalmology 100,1312-1317(1993). |
|
|